Annual Cash & Cash Equivalents:
$257.07M+$248.80M(+3009.94%)Summary
- As of today, CGON annual cash & cash equivalents is $257.07 million, with the most recent change of +$248.80 million (+3009.94%) on December 31, 2024.
- During the last 3 years, CGON annual cash & cash equivalents has risen by +$203.46 million (+379.54%).
- CGON annual cash & cash equivalents is now at all-time high.
Performance
CGON Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$680.26M+$19.21M(+2.91%)Summary
- As of today, CGON quarterly cash & cash equivalents is $680.26 million, with the most recent change of +$19.21 million (+2.91%) on September 30, 2025.
- Over the past year, CGON quarterly cash & cash equivalents has increased by +$139.55 million (+25.81%).
- CGON quarterly cash & cash equivalents is now -8.32% below its all-time high of $742.00 million, reached on December 31, 2024.
Performance
CGON Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CGON Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +3009.9% | +25.8% |
| 3Y3 Years | +379.5% | +374.1% |
| 5Y5 Years | +379.5% | +374.1% |
CGON Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +3009.9% | -8.3% | +374.1% |
| 5Y | 5-Year | at high | +3009.9% | -8.3% | +374.1% |
| All-Time | All-Time | at high | +3009.9% | -8.3% | +374.1% |
CGON Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $680.26M(+2.9%) |
| Jun 2025 | - | $661.05M(-4.0%) |
| Mar 2025 | - | $688.43M(-7.2%) |
| Dec 2024 | $257.07M | $742.00M(+37.2%) |
| Sep 2024 | - | $540.71M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $552.88M(-2.4%) |
| Mar 2024 | - | $566.51M(+201.9%) |
| Dec 2023 | $8.27M(-90.6%) | $187.67M(+30.8%) |
| Dec 2022 | $88.14M(+64.4%) | - |
| Dec 2022 | - | $143.48M |
| Dec 2021 | $53.61M | - |
FAQ
- What is CG Oncology, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for CG Oncology, Inc.?
- What is CG Oncology, Inc. annual cash & cash equivalents year-on-year change?
- What is CG Oncology, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for CG Oncology, Inc.?
- What is CG Oncology, Inc. quarterly cash & cash equivalents year-on-year change?
What is CG Oncology, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CGON is $257.07M
What is the all-time high annual cash & cash equivalents for CG Oncology, Inc.?
CG Oncology, Inc. all-time high annual cash & cash equivalents is $257.07M
What is CG Oncology, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CGON annual cash & cash equivalents has changed by +$248.80M (+3009.94%)
What is CG Oncology, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CGON is $680.26M
What is the all-time high quarterly cash & cash equivalents for CG Oncology, Inc.?
CG Oncology, Inc. all-time high quarterly cash & cash equivalents is $742.00M
What is CG Oncology, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CGON quarterly cash & cash equivalents has changed by +$139.55M (+25.81%)